A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Angelina Jolie has shockingly faced a torrent of callous online abuse after boldly baring the scars from her double ...

Hollywood star Angelina Jolie found herself at the center of an online firestorm after a new magazine photoshoot reignited ...

Zosia Miedzybrodzka has been appointed an Officer of the Order of the British Empire (OBE) for her services to genetics ...

DECADES of virology research that yielded the human papillomavirus (HPV) vaccine and identified the virus as a primary cause ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Breast cancer is a formidable foe that impacts the lives of countless women worldwide. Early detection is paramount in the fight against this disease, as it can significantly improve treatment ...

For many years, breast cancer screening has followed a simple rule: most women are advised to start having yearly mammograms ...

Holiday family gatherings offer a great opportunity to create valuable new memories with our loved ones, and to share ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.